What a shared longevity dataset would actually hold

MERIDIAN — Ask anyone here what the joint-audit framework contains and you get a number before you get an answer. Four hundred seventeen. That is the count of people across three completed cohorts — 139 apiece — who received Meridian's longevity protocol and finished thirty days with clean markers. The directorate offers the figure the way a hospital offers a survival rate. Proudly. Without footnotes.

The footnotes are the story. I spent a week reading the draft framework that Meridian and Earth's longevity therapy board are still negotiating, the shared dataset neither party would own, and on inspection it is three documents wearing one cover. Understanding what each contains is the whole quarrel. So take them in order.

The outcomes

The first tranche is cohort outcomes: baseline biomarkers, the protocol as administered, thirty-day panels for each clean cohort. This is the part Meridian wants the galaxy to see. The panels, by every reading I was shown, are unremarkable in the good way — the way a chest film is unremarkable when nothing is broken. Earth's board does not dispute the numbers so much as their provenance. A result you were never permitted to observe being generated is not, to a regulator, a result. It is a press release with error bars.

"We are not asking whether their charts look good," one board member told me, on condition I not name her employer. "We are asking to hold the instrument that produced them. Those are different requests, and Meridian keeps answering the first one."

The logs

The second tranche is the adverse-event logs, and here the framework is generous to a point of suspicion. The second and third cohorts logged nothing, and the directorate hands over the empty registers freely, which is the easiest gift in medicine to give. An empty log is either a healthy population or an incurious one; the log itself won't tell you which. The first cohort is where the register stops being empty. It numbered 140, not 139 — the extra body a retired desalination engineer who developed a fever of unexplained origin that later resolved.

The nine pages

Which brings us to the third document, or rather its absence. Nine pages of that engineer's medical record remain sealed. Earth's board has requested them four times. Meridian's directorate has refused four times, and once the sealed file survived a clean second month, the colony's argument shifted from not yet to not necessary — a fever that resolved, in a protocol that has since run three clean cohorts, is a closed chapter, and reopening it serves the auditor's curiosity rather than the patient's health.

I have some sympathy for that. I also have some training, and the training says the chart tells a different story. The anomalies you seal are exactly the ones worth reading, because the clean cohorts are already telling you what you hoped to hear, and confirmation is the cheapest data there is. You seal the fever file to protect the patient. You also, conveniently, protect the program. Meridian has never volunteered which motive is load-bearing, and I'd guess it doesn't know itself.

Underneath the framework sits the question no clause resolves: can Earth assert authority over a therapy it has never been permitted to examine? The board says examination is the entire point of the exercise. Meridian says the exercise is Earth's cartel dressed as caution, and that a dataset owned by neither is the most sovereignty it will spend.

A fourth charter departs for Meridian in sixty-one days. Every berth is sold, 139 passengers, and it will arrive whether the nine pages open or not. When the dataset is finished it will hold three clean cohorts and two empty registers. It will also hold a locked drawer. The drawer will decide more than the cohorts do — that's not a metaphor, it's just how audits work.